What lit Durata's touch paper this week?
This article was originally published in Scrip
Executive Summary
There was a high volume of trading in shares of Durata Therapeutics and the firm's stock price spiked up 19% to $15.17 on 4 August, giving it a market cap of $404m. The jury is out on exactly what set the stock alight that day.